Support from readers like you keeps The Journal open.
You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.
If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.
IRELAND’S MEDICINES REGULATOR has said the Irish government is right to wait for approval from the European Medicines Agency (EMA) before using any vaccines.
Speaking to The Journal, Dr Lorraine Nolan, Chief Executive of the Health Products Regulatory Authority (HPRA) said it is important that the regulatory system for vaccines is seen to be robust so people have confidence in Covid-19 jabs.
Although a definitive link with rare blood clotting conditions has not been established, the European regulator has advised that vaccinators and those receiving the jab should be made aware of symptoms while it conducts further investigations.
“The decision to update the vaccine information is precautionary and it’s unusual for them to do that given a link hasn’t been proven,” she said. “But this will provide information for healthcare professionals on occurrence and it will let both healthcare professionals and patients know what to look out for”.
There have been calls for Ireland to address the current shortage in vaccine supplies by ordering jabs from manufacturers who have not yet received Conditional Marketing Authorisation (CMA) from the EMA.
Currently there are four vaccines approved by the European regulator; the Pfizer/BioNTech vaccine, the Moderna vaccine, the Oxford/AstraZeneca jab and the Janssen (Johnson & Johnson) vaccine.
Hungary has begun using both the Chinese Sinopharm and the Russian Sputnik V vaccines, despite the fact that neither have received the green light from the EMA. EU member states Slovakia and Czech Republic have also started administering doses of the Russian vaccine before EMA approval.
Advertisement
On Friday the Russian Ambassador to Ireland Yuriy Filatov, said his home country is ready to help vaccinate people in Ireland against Covid-19.
He said the Irish authorities had not yet approached Russia about ordering its Sputnik V vaccine, which President Vladamir Putin is due to receive today.
“The government viewpoint is one I totally confer with,” Dr Nolan said. “There’s that question of are we approving things too fast or too slow and the thing about the EU system is that there are established procedures. We can see that safety is a number one priority and it’s important that they are put through the highest level of scrutiny.
That’s not to say the Sputnik V vaccine isn’t something we’d consider safe. A rolling review has been started by the EMA and that means they are reviewing the data in realtime as its generated. So they have started to look at the non-clinical and clinical packages.
“It’s hard to know timewise when this might come through. The telling point will be when the Gamaleya Research Institute, which developed the vaccine, is told to submit an application for Conditional Marketing Authorisation. Once we reach that point we’ll have a better indication of timing – it normally takes three to four weeks from that point.”
Two other vaccines – Curevac and Novavax – are also currently undergoing rolling reviews.
Nolan said the PRAC consulted heavily with experts in blood coagulation and clotting and in neurology from across the European system.
The resumption of the use of the AstraZeneca vaccine in Ireland should help to address supply issues, particularly as we move into the second quarter of the year, with significantly increased deliveries expected from all manufacturers.
Dr Nolan said she can understand that people may be concerned about getting the AStraZeneca vaccine after seeing recent news about the potential link to blood clotting conditions, but stressed that all EMA-approved vaccines have had to go through large clinical trials and the same safety standards of pre-pandemic vaccines.
A review by the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) found there was no increased risk of blood clots following am AstraZeneca jab, with just 18 of the two severe conditions identified out of almost 20 million vaccinated people.
Related Reads
AstraZeneca vaccine 100% effective against 'severe' Covid, data from US-led trial shows
AstraZeneca rollout resumes in Ireland after pause as EU threatens company with export ban
The EMA has declared the AstraZeneca vaccine safe to use - here's what happens next
The conditions in question are cerebral venous sinus thrombosis (CVST), which involves clotting in the veins at the back of the brain and disseminated intravascular coagulation (DIC), which involves multiple clots across the vein structure.
Dr Nolan said even if a definitive link between the vaccine and these very rare conditions is identified, there is still “a very strong case for vaccination”.
“I’ve always said, and we’ve been open and transparent about this from the beginning, clinical trials are carried out with tens of thousands of people and when you go on to use a vaccine on millions and billions of people there is always potential that this escalation in scale could throw up very rare side effects not shown in a clinical trial,” she said.
“Vaccines have such an important role to play, we need as many as possible authorised and we need to vaccinate as many people as possible because we know the serious risks associated with Covid-19.
“It has yet to be proven that these very rare cases are linked [to the vaccine] but if they are we can indicate the frequency and characterise it and hopefully identify people who are at risk as well as identifying treatment pathways for them.”
The refreshed EMA guidance lists a number of symptoms for patients to be aware of following their vaccine:
breathlessness,
pain in the chest or stomach,
swelling or coldness in an arm or leg,
severe or worsening headache or blurred vision after vaccination,
persistent bleeding,
multiple small bruises, reddish or purplish spots, or blood blisters under the skin,
Neither of the two conditions in question have been reported in Ireland following vaccination and general incidence of these conditions is rare.
Dr Nolan said the best experts in haematology and neurology in Europe will come together now and conduct a range of tests as well as looking at observational studies to try to determine whether there is a link.
Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article.
Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.
To embed this post, copy the code below on your site
Close
23 Comments
This is YOUR comments community. Stay civil, stay constructive, stay on topic.
Please familiarise yourself with our comments policy
here
before taking part.
No smoke without fire. An eradication of morale would fit with the recent reports on banning its members from partaking in a dance that every other emergency and voluntary rescue service in the country took part in. Publicising the organisation for all the wrong reasons. I don’t think I’d have much confidence in the management.
@David Corrigan: wow that’s a fairly baseless accusation, one would have to wonder if there’s any connections between yourself and the unofficial survey that has no accountability or transparency (see I can do it too)
@Anto Curran: Their own commissioned survey paints them in good light while the “unofficial” survey says that things are not so good within camp. Couple this to the fact that there is plenty of evidence of underhanded behaviour in this country means that there will always be suspicions around internally driven surveys.
It’s not that hard to understand Anto is it?
@David Corrigan: those ‘Great places to work’ are a joke. A company I worked for won it once. They had more staff out on mental health issues due to senior directors and bully boy tactics.
Just as an aside, any sign of the official report on R116 crash in March 2017 (that would be fully 4 years ago) ever being published?? Not aware of any equivalent accident where within a couple of days they had the wreckage + a rough idea of what had happened, yet four years on people still waiting for the official accident report.
Zelenskyy leaves White House summit after Trump claims he's 'not ready for peace'
Updated
48 mins ago
39.9k
227
Rome
Pope Francis put on mechanical ventilation, as prognosis remains 'guarded'
Updated
44 mins ago
15.8k
New Mexico
Police 'keeping everything on the table' in deaths of Gene Hackman and wife Betsy Arakawa
Updated
21 hrs ago
104k
78
Your Cookies. Your Choice.
Cookies help provide our news service while also enabling the advertising needed to fund this work.
We categorise cookies as Necessary, Performance (used to analyse the site performance) and Targeting (used to target advertising which helps us keep this service free).
We and our 153 partners store and access personal data, like browsing data or unique identifiers, on your device. Selecting Accept All enables tracking technologies to support the purposes shown under we and our partners process data to provide. If trackers are disabled, some content and ads you see may not be as relevant to you. You can resurface this menu to change your choices or withdraw consent at any time by clicking the Cookie Preferences link on the bottom of the webpage .Your choices will have effect within our Website. For more details, refer to our Privacy Policy.
We and our vendors process data for the following purposes:
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised advertising and content, advertising and content measurement, audience research and services development.
Cookies Preference Centre
We process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent. You may exercise your right to consent, based on a specific purpose below or at a partner level in the link under each purpose. Some vendors may process your data based on their legitimate interests, which does not require your consent. You cannot object to tracking technologies placed to ensure security, prevent fraud, fix errors, or deliver and present advertising and content, and precise geolocation data and active scanning of device characteristics for identification may be used to support this purpose. This exception does not apply to targeted advertising. These choices will be signaled to our vendors participating in the Transparency and Consent Framework.
Manage Consent Preferences
Necessary Cookies
Always Active
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then these services may not function properly.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not be able to monitor our performance.
Store and/or access information on a device 105 partners can use this purpose
Cookies, device or similar online identifiers (e.g. login-based identifiers, randomly assigned identifiers, network based identifiers) together with other information (e.g. browser type and information, language, screen size, supported technologies etc.) can be stored or read on your device to recognise it each time it connects to an app or to a website, for one or several of the purposes presented here.
Personalised advertising and content, advertising and content measurement, audience research and services development 137 partners can use this purpose
Use limited data to select advertising 106 partners can use this purpose
Advertising presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type or which content you are (or have been) interacting with (for example, to limit the number of times an ad is presented to you).
Create profiles for personalised advertising 79 partners can use this purpose
Information about your activity on this service (such as forms you submit, content you look at) can be stored and combined with other information about you (for example, information from your previous activity on this service and other websites or apps) or similar users. This is then used to build or improve a profile about you (that might include possible interests and personal aspects). Your profile can be used (also later) to present advertising that appears more relevant based on your possible interests by this and other entities.
Use profiles to select personalised advertising 78 partners can use this purpose
Advertising presented to you on this service can be based on your advertising profiles, which can reflect your activity on this service or other websites or apps (like the forms you submit, content you look at), possible interests and personal aspects.
Create profiles to personalise content 38 partners can use this purpose
Information about your activity on this service (for instance, forms you submit, non-advertising content you look at) can be stored and combined with other information about you (such as your previous activity on this service or other websites or apps) or similar users. This is then used to build or improve a profile about you (which might for example include possible interests and personal aspects). Your profile can be used (also later) to present content that appears more relevant based on your possible interests, such as by adapting the order in which content is shown to you, so that it is even easier for you to find content that matches your interests.
Use profiles to select personalised content 34 partners can use this purpose
Content presented to you on this service can be based on your content personalisation profiles, which can reflect your activity on this or other services (for instance, the forms you submit, content you look at), possible interests and personal aspects. This can for example be used to adapt the order in which content is shown to you, so that it is even easier for you to find (non-advertising) content that matches your interests.
Measure advertising performance 127 partners can use this purpose
Information regarding which advertising is presented to you and how you interact with it can be used to determine how well an advert has worked for you or other users and whether the goals of the advertising were reached. For instance, whether you saw an ad, whether you clicked on it, whether it led you to buy a product or visit a website, etc. This is very helpful to understand the relevance of advertising campaigns.
Measure content performance 60 partners can use this purpose
Information regarding which content is presented to you and how you interact with it can be used to determine whether the (non-advertising) content e.g. reached its intended audience and matched your interests. For instance, whether you read an article, watch a video, listen to a podcast or look at a product description, how long you spent on this service and the web pages you visit etc. This is very helpful to understand the relevance of (non-advertising) content that is shown to you.
Understand audiences through statistics or combinations of data from different sources 75 partners can use this purpose
Reports can be generated based on the combination of data sets (like user profiles, statistics, market research, analytics data) regarding your interactions and those of other users with advertising or (non-advertising) content to identify common characteristics (for instance, to determine which target audiences are more receptive to an ad campaign or to certain contents).
Develop and improve services 82 partners can use this purpose
Information about your activity on this service, such as your interaction with ads or content, can be very helpful to improve products and services and to build new products and services based on user interactions, the type of audience, etc. This specific purpose does not include the development or improvement of user profiles and identifiers.
Use limited data to select content 39 partners can use this purpose
Content presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type, or which content you are (or have been) interacting with (for example, to limit the number of times a video or an article is presented to you).
Use precise geolocation data 43 partners can use this special feature
With your acceptance, your precise location (within a radius of less than 500 metres) may be used in support of the purposes explained in this notice.
Actively scan device characteristics for identification 25 partners can use this special feature
With your acceptance, certain characteristics specific to your device might be requested and used to distinguish it from other devices (such as the installed fonts or plugins, the resolution of your screen) in support of the purposes explained in this notice.
Ensure security, prevent and detect fraud, and fix errors 87 partners can use this special purpose
Always Active
Your data can be used to monitor for and prevent unusual and possibly fraudulent activity (for example, regarding advertising, ad clicks by bots), and ensure systems and processes work properly and securely. It can also be used to correct any problems you, the publisher or the advertiser may encounter in the delivery of content and ads and in your interaction with them.
Deliver and present advertising and content 97 partners can use this special purpose
Always Active
Certain information (like an IP address or device capabilities) is used to ensure the technical compatibility of the content or advertising, and to facilitate the transmission of the content or ad to your device.
Match and combine data from other data sources 69 partners can use this feature
Always Active
Information about your activity on this service may be matched and combined with other information relating to you and originating from various sources (for instance your activity on a separate online service, your use of a loyalty card in-store, or your answers to a survey), in support of the purposes explained in this notice.
Link different devices 51 partners can use this feature
Always Active
In support of the purposes explained in this notice, your device might be considered as likely linked to other devices that belong to you or your household (for instance because you are logged in to the same service on both your phone and your computer, or because you may use the same Internet connection on both devices).
Identify devices based on information transmitted automatically 85 partners can use this feature
Always Active
Your device might be distinguished from other devices based on information it automatically sends when accessing the Internet (for instance, the IP address of your Internet connection or the type of browser you are using) in support of the purposes exposed in this notice.
Save and communicate privacy choices 65 partners can use this special purpose
Always Active
The choices you make regarding the purposes and entities listed in this notice are saved and made available to those entities in the form of digital signals (such as a string of characters). This is necessary in order to enable both this service and those entities to respect such choices.
have your say